H. Baghi, S. Noorbaloochi, and J. Moore. Quality management in health care, 16 (2):
104-12(2007)5152<m:linebreak></m:linebreak>JID: 9306156; RF: 65; ppublish;<m:linebreak></m:linebreak>Significació estadística.
Y. Chi, and C. Chen. Statistics in medicine, 27 (29):
6175-89(December 2008)5263<m:linebreak></m:linebreak>LR: 20090730; JID: 8215016; 0 (Antineoplastic Agents); 33419-42-0 (Etoposide); ppublish;<m:linebreak></m:linebreak>Fase II.
L. Bax, N. Ikeda, N. Fukui, Y. Yaju, H. Tsuruta, and K. Moons. American journal of epidemiology, 169 (2):
249-55(January 2009)5062<m:linebreak></m:linebreak>JID: 7910653; 2008/12/08 aheadofprint; ppublish;<m:linebreak></m:linebreak>Metaanàlisi; Presentació de dades.
J. Llorca, and M. Delgado-Rodríguez. Medical science monitor : international medical journal of experimental and clinical research, 8 (10):
MT193-7(October 2002)3579<m:linebreak></m:linebreak>Risc atribuïble.
M. Petticrew, P. Tugwell, E. Kristjansson, S. Oliver, E. Ueffing, and V. Welch. Journal of epidemiology and community health, 66 (1):
95-8(January 2012)6430<m:linebreak></m:linebreak>JID: 7909766; 2011/06/06 aheadofprint; ppublish;<m:linebreak></m:linebreak>Comparacions múltiples; Anàlisi de subgrups.
A. Odueyungbo, L. Thabane, and M. Markle-Reid. Nurse researcher, 16 (4):
73-83(January 2009)5328<m:linebreak></m:linebreak>JID: 9435953; RF: 15; ppublish;<m:linebreak></m:linebreak>Límits de confiança; Mesures de contrast.